(19)
(11) EP 2 968 182 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.07.2018 Bulletin 2018/30

(45) Mention of the grant of the patent:
09.05.2018 Bulletin 2018/19

(21) Application number: 14722867.0

(22) Date of filing: 14.03.2014
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 47/34(2017.01)
 A61K 9/46(2006.01)
A61K 31/485(2006.01)
(86) International application number:
PCT/US2014/027176
(87) International publication number:
WO 2014/152296 (25.09.2014 Gazette 2014/39)

(54)

ABUSE DETERRENT SOLID DOSAGE FORM FOR IMMEDIATE RELEASE WITH FUNCTIONAL SCORE

MISSBRAUCHSSICHERE FESTE DOSIERUNGSFORM ZUR SCHNELLEN FREISETZUNG MIT FUNKTIONELLER KERBE

FORME GALÉNIQUE SOLIDE DISSUASIVE D'ABUS POUR LIBÉRATION IMMÉDIATE AVEC MARQUE FONCTIONNELLE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.03.2013 US 201361792951 P

(43) Date of publication of application:
20.01.2016 Bulletin 2016/03

(73) Proprietor: SpecGx LLC
Webster Groves, Missouri 63119 (US)

(72) Inventors:
  • RAMAN, Siva, N.
    St. Louis, Missouri 63141 (US)
  • PARK, Jae Han
    Olivette, Missouri 63132 (US)
  • BATTU, Sunil, K.
    Manchester, Missouri 63021 (US)
  • BURGE, Eric, A.
    Collinsville, Illinois 62234 (US)
  • BOGAN, David, W.
    Wentzville, Missouri 63385 (US)

(74) Representative: Jones, Nicholas Andrew 
Withers & Rogers LLP 4 More London Riverside
London, SE1 2AU
London, SE1 2AU (GB)


(56) References cited: : 
WO-A1-2006/002836
 WO-A1-2011/079074
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).